GAMELIN ERICK (Chief Development Officer) reported 1 transaction at ACRIVON THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/18/2026ACC: 0000905148-26-000936
Officer· Chief Development Officer
Since Mar 2026
-471.00
Net shares
Net seller
$767.73
Total sold
0
Open market trades
0B · 0S
1
Total transactions
471.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−471.00
Price / share
$1.63
Trade value
$767.73
% of position
3.1%
2/14/2026
15.28K→14.81K
Total
Net shares
−471.00
Net value
-$767.73
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2026 | F · Tax Withholding | −471.00 | $1.63 | $767.73 | 3.1% | 15.28K | 14.81K |
| Total | −471.00 | -$767.73 | ||||||
Derivative Transactions0
No derivative transactions reported